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differentiation via miR-19b-modulated Sox6
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Abstract 
Background: Regulating cardiac differentiation to maintain normal heart development and function is very impor-
tant. At present, biological functions of H19 in cardiac differentiation is not completely clear.
Methods: To explore the functional effect of H19 during cardiac differentiation. Expression levels of early cardiac-spe-
cific markers Nkx-2.5 and GATA4, cardiac contractile protein genes α-MHC and MLC-2v were determined by qRT-PCR 
and western lot. The levels of lncRNA H19 and miR-19b were detected by qRT-PCR. We further predicted the binding 
sequence of H19 and miR-19b by online softwares starBase v2.0 and TargetScan. The biological functions of H19 and 
Sox6 were evaluated by CCK-8 kit, cell cycle and apoptosis assay and caspase-3 activity.
Results: The expression levels of α-MHC, MLC-2v and H19 were upregulated, and miR-19b was downregulated 
significantly in mouse P19CL6 cells at the late stage of cardiac differentiation. Biological function analysis showed that 
knockdown of H19 promoted cell proliferation and inhibits cell apoptosis. H19 suppressed miR-19b expression and 
miR-19b targeted Sox6, which inhibited cell proliferation and promoted apoptosis in P19CL6 cells during late-stage 
cardiac differentiation. Importantly, Sox6 overexpression could reverse the positive effects of H19 knockdown on 
P19CL6 cells.
Conclusion: Downregulation of H19 promoted cell proliferation and inhibited cell apoptosis during late-stage car-
diac differentiation by regulating the negative role of miR-19b in Sox6 expression, which suggested that the manipu-
lation of H19 expression could serve as a potential strategy for heart disease.
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Background
The heart comes into being by undergoing many devel-
opmental events such as determination of the cardiac 
field in the mesoderm, differentiation of cardiac pre-
cursor cells into cardiomyocytes, and morphogenesis 
of the chambered heart [1]. Moreover, a series of gene 
expressions take part in the formation of the mature 
vertebrate heart with separated chambers and valves 
[2]. Large numbers of genes play key roles in cardiac 
morphogenesis, though their precise function and their 
interaction with other cardiac regulators are not well 
known [3]. Many embryonic researches have indicated 
the mechanisms of how and where these steps occur dur-
ing embryonic development period [4]. However, there 
is little understanding of the molecular mechanisms that 
modulate these induced events in the process of the heart 
formation. P19CL6, a euploid and multipotent mouse cell 
line, are derived from P19 embryonal carcinoma cells, 
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and DMSO treatment makes P19CL6 differentiate effi-
ciently into cardiac myocytes with obviously spontane-
ous heartbeat within 10 days [5]. P19CL6 is considered to 
be a helpful model in vitro to investigate cardiomyocyte 
differentiation [6].
LncRNAs are a type of approximately 200-nucleo-
tide (nt)-long RNA molecules without protein-coding 
potential and stably exist in the plasma and urine, and 
have the characteristics of disease and tissue specificity 
[7]. Growing research has indicated that lncRNAs are 
often abnormally expressed in many cancers and play a 
variety of biological functions in cell proliferation, apop-
tosis, or invasion [7, 8]. LncRNAs modulate gene expres-
sion at multiple levels such as epigenetic, transcriptional 
and post transcriptional regulation [9]. H19, the first 
imprinted lncRNA to be defined, is conserved across lin-
eages [10]. Gabory et al. demonstrated that H19−/−mice 
presented an overgrowth phenotype, while overexpress-
ing H19 in transgenic mice caused postnatal growth 
reduction [11]. It is important for understanding the car-
diac development to illuminate the mechanisms of gene 
regulation. However, the precise function of H19 in car-
diac differentiation is yet unascertained.
microRNAs (miRNAs) are endogenous regulatory 
RNAs, having important effects on heart development 
and pathogenesis [12]. miR-19b is part of the miR-17-92 
group which encodes miR-17, miR-18a, miR-19a, miR-
19b, miR-20a and miR-92a-1, and promotes the devel-
opment of heart, lung, blood vessel and immune system 
[13]. Cardiogenesis is seriously inhibited in mice lacking 
miR-17-92, indicating its vital role in cardiac develop-
ment [13]. A previous study showed that miR-19b over-
expression promoted cell proliferation and suppressed 
apoptosis of mouse embryonic carcinoma cells (P19 cells) 
[14]. Thus, miR-19b may functionally be connected with 
cardiogenic processes, although its exact role remains 
poorly understood.
In this study, we detected the expression levels of Nkx-
2.5, GATA4, α-MHC, MLC-2v and H19 in P19CL6 cells 
at indicated time points. Then we defined the biological 
effect of H19 in regulating cell proliferation and apopto-
sis during cardiac differentiation by modulating miR-19b. 
Moreover, we examined the link between H19 and Sox6 




P19CL6 mouse embryonic carcinoma cells were grown 
in Minimum Essential Medium, Alpha Medium (a-MEM; 
GIBCO, Carlsbad, CA, USA) containing 10% fetal bovine 
serum (FBS; GIBCO). 293T cells (ATCC; Manassas, 
VA, USA) were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; GIBCO) containing 10% FBS. The cells 
were kept at 37 °C in a humidified incubator with 5% CO2 
atmosphere.
To induce P19CL6 cells to differentiate into car-
diomyocytes, P19CL6 cells were seeded at a density of 
3.5 ×  105 cells/well in a six-well plate with the culture 
medium containing 1% dimethyl sulfoxide (DMSO; 
Sigma, St. Louis, MO, USA). The conditioned medium 
was replaced with 2 ml of fresh medium containing 1% 
DMSO every 2  days. The days of differentiation were 
numbered consecutively following the first day of the 
DMSO treatment (day 0).
Generation of a stable cell line and transfection
Recombinant lentiviruses harboring sh-NC, shH19, H19, 
si-NC, si-Sox6 or Sox6 were purchased from the Gene-
Chem Company (Shanghai, China). To construct the 
stable cell line, P19CL6 cells were transfected with lenti-
viruses and then puromycin (2 µg/ml) was used to select 
the stable cell line for a week. miR-NC, miR-19b mimics, 
miR-NC and anti-miR-19b were chemically synthesized 
by Genechem Company. Briefly, each oligonucleotide 
was transiently transfected into P19CL6 cells by means 
of Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) 
at 20  nM according to the manufacturer’s instructions. 
Samples were collected for qRT-PCR, western blot, cell 
viability assay or flow cytometry at the indicated time 
points.
RNA isolation and quantitative real‑time PCR
For mRNA analysis, total RNA was extracted from 
P19CL6 cells using TRIzol reagent (Thermo Fisher Sci-
entific, Waltham, MA, USA). The reverse-transcription 
reactions were carried out using a TaqMan™ microRNA 
assay kit (Applied Biosystems, Foster City, CA, USA) and 
a Prime Script™ RT reagent kit (Takara, Shiga, Japan) 
according to the instructions from the respective manu-
facturers. Quantitative PCR was carried out in a final 
volume of 20  μl containing 1  μl cDNA, 0.5  μl primers 
(2.5 μM) and 10 μl SYBR premix exTaq (TaKaRa, Dalian, 
China) following the manufacturer’s instructions.
CCK‑8 assay
Cell viability was detected using Cell Counting kit-8 
(CCK-8; Dojindo, Kumamoto, Japan) following the 
manufacturer’s instructions. P19CL6 cells transfected 
with H19, shH19, Sox6 or si-Sox6 were plated in 96-well 
plates and maintained in α-MEM containing 10% FBS, 
100 U/ml penicillin and 100  μg/ml streptomycin for 4, 
6, 8, and 10 d. Briefly, the CCK-8 solution (10% of the 
medium, 10 µl) was added to each well and incubated for 
4 h prior to analysis. Then the absorbance at 450 nm was 
measured.
Page 3 of 11Han et al. Cell Biosci  (2016) 6:58 
Flow cytometry analysis of apoptosis and cell cycle
For apoptosis analysis, cultured cells were trypsinized 
and washed with phosphate-buffered saline (PBS). Cells 
from each sample were processed with the Annexin 
V-FITC/PI apoptosis detection kit (BD Biosciences, San 
Jose, CA, USA) as the manufacturer’s instructions at 
indicated times.
For cell cycle analysis, collected cells were washed 
twice with PBS and fixed in 75% ethanol at −20 °C over-
night. Then cells were harvested and resuspended in 
500 µl PBS containing 0.1% RNase (Sigma, St. Louis, MO, 
USA) for RNA digestion. Finally, cells were stained with 
500 µl propidium iodide (PI) solution (50 µg/ml, Sigma) 
for 15  min at room temperature in the dark. Cell cycle 
distribution of the cells was then analyzed using FACS 
Calibur (BD Biosciences) at indicated times.
Caspase‑3 assay
Caspase-3 activity in P19CL6 cells was analyzed by 
means of Caspase-3 Colorimetric Assay kit (KeyGen, 
Nanjing, China) following the manufacturer’s instruc-
tions. In brief, cells were lysed in ice bath for 1  h and 
vortexed every 20 min. Then the tissue lysates were cen-
trifuged for 10  min at 12,000g at 4  °C. The supernatant 
were diluted to 50 µl using cell lysis buffer, incubated with 
5 µl of substrate at 37 °C for 4 h in dark and a microplate 
reader (DNM-9602; Beijing Perlong Medical Instrument 
Ltd, Beijing, China) was used to determine the absorb-
ance of the samples at 405 nm to quantify the caspase-3 
activity.
Luciferase assay
The wild-type H19-3′UTR (WT), mutant H19-3′UTR 
(MUT), wild-type Sox6-3′UTR (WT) and mutant Sox6-
3′UTR (MUT) containing the putative binding site of 
miR-19b were established and cloned in pmirGLO dual 
luciferase miRNA reporter vectors (Promega, Madison, 
WI, USA). The reporter vectors and miR-19b mimics or 
miR-NC were co-transfected into 293T cells using Lipo-
fectamine 2000 (Invitrogen). After 36  h of incubation, 
cells were collected and lysed for luciferase activity detec-
tion (Promega).
Antibodies and western blot analysis
Total protein was extracted from cells and protein con-
centration was analyzed by a NanoDrop 2000 spectro-
photometer (Thermo Scientific, Delaware, USA). For 
western blot analysis, 50  µg of proteins were separated 
and transferred onto polyvinylidene difluoride membrane 
(PVDF; Millipore, Billerica, MA, USA). Following block-
ing for 1  h in PBS with 0.1% Tween 20 (PBST) and 5% 
BSA, the membranes containing proteins of interest were 
incubated overnight with specified primary antibody 
at 4  °C. PVDF membranes were washed in TBST and 
incubated with secondary antibodies labeled with HRP 
and detected by ECL (Pierce, Rockford, IL, USA). Anti-
bodies used in this study are Nkx-2.5 (1:500; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), GATA4 (1:500; 
Santa Cruz Biotechnology), α-MHC (1:500; Santa Cruz 
Biotechnology), MLC-2v (1:500; Santa Cruz Biotechnol-
ogy), Sox6 (1:10,000; CST, Inc., Danvers, MA, USA), and 
β-actin (1:10,000; CST, Inc.).
Statistical analysis
Data were presented as mean  ±  SD of at least three 
experiments. The differences between different groups 
were analyzed using student’s t test and analysis of vari-
ance (ANOVA). P  <  0.05 was considered statistically 
significant.
Results
H19 was highly expressed in the late stage of cardiac 
differentiation in P19CL6 cells
We treated P19CL6 cells with 1% dimethyl sulfoxide 
(DMSO) to induce differentiation. qRT-PCR was carried 
out to detect the expression levels of early cardiac-spe-
cific markers (GATA4 and Nkx-2.5), cardiac contractile 
protein genes (α-MHC and MLC-2v) in P19CL6 cells at 
indicated time points. The results showed that mRNA 
and protein levels of GATA4 and Nkx2.5 were very low 
at day 0, but increased significantly at day 4 and day 6, an 
early stage of differentiation (Fig. 1a and b). mRNA and 
protein levels of α-MHC and MLC-2v in P19CL6 cells 
were significantly higher at day 10 and 12 (an late stage 
of differentiation) than those in P19CL6 cells at day 8 
(Fig. 1c and d). In order to define the temporal expression 
profile of H19 during cardiomyocyte differentiation, we 
carried out qRT-PCR for H19. The expression of H19 was 
low at day 0, 4 and 6, but elevated significantly from day 
8 to day 12 (Fig. 1e). Moreover, the level of miR-19b was 
significantly reduced from day 8 to day 12, suggesting 
that H19 and miR-19b might play some biological roles 
during the late stage of cardiac differentiation of P19CL6 
cells (Fig. 1f ).
Knockdown of H19 promoted P19CL6 cell proliferation 
and inhibits apoptosis
Given that H19 might participate in the cardiac dif-
ferentiation of P19CL6 cells, P19CL6 cells were trans-
fected with the shH19 or pcDNA-H19. qRT-PCR results 
showed that H19 expression was significantly decreased 
in P19CL6 cells transfected with shH19 and H19 expres-
sion was significantly increased in P19CL6 cells trans-
fected with pcDNA-H19 (Fig. 2a).
CCK-8 assay showed that cell viability was sig-
nificantly enhanced in P19CL6 cells with shH19 and 
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significantly reduced in P19CL6 cells with pcDNA-
H19 at day 8 and 10, with no significantly difference at 
day 4 and 6 (Fig.  2b). Flow cytometry showed that the 
percentage of (S + G2/M)/(G0 + G1) was significantly 
increased in P19CL6 cells with shH19 and significantly 
decreased in P19CL6 cells with pcDNA-H19 at day 8 
and 10, with no significantly difference at day 4 and 6 
(Fig.  2c). These results suggested that that H19 over-
expression significantly inhibited cell proliferation and 
H19 knockdown significantly promoted cell prolifera-
tion in the late stage of differentiation but not in the 
early stage.
Fig. 1 The expression levels of GATA4, Nkx-2.5, α-MHC, MLC-2v and H19 are significantly upregulated and miR-19b was downregulated at indicated 
time points. a mRNA levels of early cardiac-specific markers (GATA4 and Nkx-2.5α-MHC) were increased significantly in P19CL6 cells at day 4 and 6. b 
Protein levels of GATA4 and Nkx-2.5α-MHC were augmented significantly in P19CL6 cells at day 4 and 6. c mRNA levels of cardiac contractile protein 
genes (α-MHC and MLC-2v) were increased significantly in P19CL6 cells at day 10 and 12. d Protein levels of α-MHC and MLC-2v were elevated 
significantly in P19CL6 cells at day 10 and 12. e Level of H19 was augmented significantly from day 8 to day 12. f Level of miR-19b was dropped 
significantly from day 8 to day 12. **P < 0.01, ***P < 0.001
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Cell apoptosis assay showed that shH19 significantly 
reduced the apoptotic rate of cells (Fig. 2d) and the cas-
pase-3 activity (Fig.  2e) at day 8 and day 10, and the 
opposite effect was observed in pcDNA-H19 cells. There-
fore, these results indicated that H19 overexpression sig-
nificantly promoted cell apoptosis and H19 knockdown 
Fig. 2 The effect of H19 knockdown and H19 overexpression on P19CL6 cell proliferation and apoptosis. a Transfecting P19CL6 cells with shH19 
and pcDNA-H19 efficiently down- and up-regulated the H19 level at day 10, respectively. b CCK-8 assay showed that shH19 resulted in an increase 
in cell viability at day 8 and 10, whereas pcDNA-H19 had an opposite effect. c Flow cytometry suggested that shH19 significantly increased the 
cell number in S phase at day 8 and 10, and pcDNA-H19 significantly decreased the cell number. d shH19 significantly reduced the apoptotic rate 
of P19CL6 cells at day 8 and day 10, whereas pcDNA-H19 had an opposite effect. e Caspase-3 assay indicated that the activity of caspase-3 was 
significantly reduced in P19CL6 cells transfected with shH19 and significantly increased in cells transfected with pcDNA-H19. *P < 0.05, **P < 0.01, 
***P < 0.001
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significantly inhibited cell apoptosis during the late stage 
of differentiation but not in the early stage.
H19 inhibited miR‑19b expression
Online software starBase v2.0 predicted H19 contains 
binding sequences complementary to miR-19b seed 
regions, as shown in Fig. 3a. Furtherly, the luciferase report 
assay indicated that miR-19b mimics inhibited lucif-
erase activity of the wild type H19 reporter (H19-WT), 
but no change was observed for the luciferase activity in 
the mutant reporter (H19-Mut) (Fig.  3b). Moreover, the 
expression level of miR-19b was significantly increased in 
cells transfected with shH19, whereas significantly reduced 
in cells with pcDNA-H19. These results indicated that H19 
negatively modulated miR-19b expression.
H19 targets miR‑19b to regulate the expression of Sox6
Bioinformatics analysis using online software Tar-
getScan indicated that miR-19b may bind to 3′UTR 
of Sox6 (Fig.  4a). In addition, luciferase reporter assay 
indicated that miR-19b significantly suppressed lucif-
erase expression of the wild type Sox6 reporter (Sox6-
WT) but not the mutant reporter (Sox6-Mut) (Fig. 4b), 
confirming that Sox6 was a target of miR-19b. West-
ern blot was used to detect the expression of Sox6 in 
the cell differentiation and the results indicated that 
the protein level of Sox6 was very low from day 0 to 
day 6, but increased significantly from day 8 to day 12 
(Fig.  4c). Then we transfected P19CL6 cells with miR-
19b mimics, miR-NC, anti-miR-19b or anti-miR-NC. 
The results showed that the protein level of Sox6 was 
significantly down-regulated in P19CL6 cells trans-
fected with miR-19b and significantly up-regulated in 
P19CL6 cells transfected with anti-miR-19b (Fig.  4d). 
Furthermore, we transfected H19-knockdown P19CL6 
cells with miR-19b mimics or anti-miR-19b. The result 
showed that knockdown H19 inhibited the Sox6 expres-
sion significantly, while miR-19b enhanced the inhibi-
tory effect of knockdown H19 on Sox6 expression, and 
anti-miR-19b reversed the influence of knockdown H19 
on Sox6 expression (Fig. 4e). All these results suggested 
that knockdown of H19 inhibited the Sox6 expression 
by modulating miR-19b.
Knockdown of Sox6 promoted P19CL6 cell proliferation 
and inhibits apoptosis
We transfected P19CL6 cells with pcDNA-Sox6 or si-Sox6. 
CCK-8 viability assay showed pcDNA-Sox6 significantly 
inhibited cell viability and si-Sox6 significantly promoted 
cell viability at day 8 and 10 (Fig.  5a). Flow cytometer 
showed found that pcDNA-Sox6 reduced the number of 
cells in S phase and si-Sox6 increased the percentage of 
Fig. 3 H19 targets and inhibits miR-19b expression. a The sketch map of the mmu-miR-19b-3p site in H19 3′-UTR. b Luciferase activity assay was 
performed in 293T cells at 48 h after transfection. miR-19b mimics were capable of significantly inhibiting luciferase expression of H19-WT reporter 
plasmid but not the H19-Mut reporter plasmid. c miR-19b levels were significantly up- or downregulated in P19CL6 cells transfected with shH19 or 
H19, respectively. **P < 0.01, ***P < 0.001
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cells in (S + G2/M)/(G0 + G1) at day 8 and 10 (Fig. 5b). As 
shown in Fig. 5c and d, si-Sox6 significantly decreased the 
percentage of apoptotic cells and the activity of caspase-3 
at day 8 and 10, while pcDNA-Sox6 significantly enhanced 
the percentage of apoptotic cells and the activity of cas-
pase-3 compared with the control group. All these results 
Fig. 4 miR-19b targets Sox6 gene and inhibits its expression. a The sketch map of the mmu-miR-19b-3p site in Sox6 3′-UTR. b Luciferase activity 
assay was performed in 293T cells at 48 h after transfection. The reporter assay indicated that miR-19b mimics were capable of significantly inhibit-
ing luciferase expression of the Sox6-WT reporter plasmid but not the Sox6-Mut reporter plasmid. c Western blot showed that protein level of Sox6 
was low from day 0 to 6, and was significantly upregulated from day 8 to 12. d The Sox6 protein levels were significantly down- and up-regulated 
respectively in P19CL6 cells transfected with miR-19b and anti-miR-19b at day 10. e shH19 inhibited the Sox6 expression significantly, but miR-19b 
enhanced the inhibitory effect of shH19 on Sox6 expression and anti-miR-19b reversed the influence of shH19 on Sox6 expression at day 10 after 
transfection. *P < 0.05, **P < 0.01, ***P < 0.001
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indicated Sox6 knockdown promoted P19CL6 cells prolif-
eration and inhibited apoptosis.
Sox6 reversed the proliferation and anti‑apoptosis effects 
of of H19 knockdown on P19CL6 cell
To further testify the link between H19 and Sox6, 
we transfected shH19 or shH19  +  pcDNA-Sox6 into 
P19CL6 cells to investigate their effects on cell prolifera-
tion and apoptosis. CCK-8 assay indicated that shH19 
significantly promoted the viability of P19CL6 cells at 
day 6, 8 and 10, but pcDNA-Sox6 attenuated the effect of 
shH19 on cell viability (Fig. 6a). Cell cycle assay indicated 
that shH19 markedly increased the percentage of cells in 
(S + G2/M)/(G0 + G1), while pcDNA-Sox6 overturned 
the effect (Fig. 6b). Futhermore, we found that the rate of 
apoptosis and caspase-3 activity were obviously reduced 
in cells treated with shH19, however, pcDNA-Sox6 
reversed the anti-apoptosis effect of shH19 on P19CL6 
cells (Fig.  6c and d). All of the data suggested that H19 
regulated P19CL6 cell proliferation and apoptosis by 
modulating Sox6 expression.
Discussion/conclusion
It is necessary for heart development that a regular pro-
cess essentially exists during cardiac differentiation. 
Furthermore, cardiac differentiation has been compre-
hensively investigated. In our study, our aim was to define 
the connection between H19 and miR-19b and its bio-
logical effect on P19CL6 during late-stage cardiomyocyte 
differentiation. One study showed that H19 had an inhib-
itory effect on the proliferation of fetal liver cells during 
liver developments [15]. Similarly, the results presented 
by Gabory et  al. confirmed that H19 played a negative 
role in cell proliferation [11]. Lately, it was reported that 
knockdown of H19 accelerated differentiation of par-
thenogenetic embryonic stem cells (p-ESCs) to cardio-
myocytes [16, 17]. Nevertheless, little is known about the 
precise molecular mechanisms of H19 in cardiomyocyte 
Fig. 5 The effect of Sox6 knockdown and overexpression on P19CL6 cell proliferation and apoptosis. a CCK-8 assay showed that pcDNA-Sox6 
significantly inhibited cell viability at day 8 and 10, and si-Sox6 significantly promoted cell viability at day 8 and 10. b Cell cycle analysis found that 
pcDNA-Sox6 significantly decreased the cell number in S phase at day 8 and 10, and si-Sox6 obviously increased the cell number. c Flow cytom-
etry showed that si-Sox6 significantly reduced the percentage of apoptotic cells from day 6 to 10. However, pcDNA-Sox6 played an opposite role 
in apoptosis at day 8 and 10. d Activity of caspase-3 was significantly reduced in cells transfected with si-Sox6 and significantly enhanced in cells 
transfected with pcDNA-Sox6. *P < 0.05, **P < 0.01, ***P < 0.001
Page 9 of 11Han et al. Cell Biosci  (2016) 6:58 
differentiation. In this study, upregulated expression of 
H19 in P19CL6 cells was observed at the late stage of 
differentiation (day 8, 10 and 12). Then, further experi-
ments were performed to detect the roles of knockdown 
of H19 in cell proliferation and apoptosis existing in car-
diomyocyte differentiation. Indeed, knockdown of H19 
promoted cell proliferation and inhibited apoptosis at the 
late stage of differentiation, but not the early stage.
There have been some reports that miRNAs can pro-
mote cardiac development and be used as new biomark-
ers and therapeutic targets for coronary heart disease 
(CHD) [18]. The results presented by Joost et  al. [19] 
showed that upregulation of miR-1 and -499 inhibited 
cardiomyocyte progenitor cell (CMPC) proliferation 
and promoted differentiation into cardiomyocytes in 
human CMPCs and embryonic stem cells, possibly by 
inhibition of histone deacetylase 4 or Sox6. CAI et  al. 
found that miR-124 was down-regulated in bone mar-
row-derived mesenchymal stem cells (BMSCs), targeted 
STAT3 and in turn influenced the levels of ANP, TNT, 
a-MHC, and GATA-4 for the first time. [20]. Recently, 
other investigators showed that miR-10a could target and 
inhibit effectively GATA6 expression, which reduced the 
proliferation of hCMPCs during heart development [21]. 
Therefore, miRNAs play a vital role in heart develop-
ment, but the specific mechanism is not completely clear. 
In this study, H19 suppressed the expression of miR-19b. 
Furthermore, we also confirmed that miR-19b could tar-
get directly Sox6 and inhibited its expression.
Sox6, a member of Sox transcription-factor family, 
is a multi-faceted transcription factor participating in 
the terminal differentiation of many different cell types 
in vertebrates [22]. Sox6 without the transactivation or 
transrepression domain is different from the majority of 
transcription factors, but interacts with other cofactors 
to collaboratively regulate target genes [23]. It is reported 
that Sox6 plays a tumor-suppressive role in cancers [24, 
25]. The results presented by Qin et al. showed that Sox6 
suppressed cell proliferation by upregulating expres-
sion levels of p53 and p21 and down-regulating expres-
sion levels of cyclin D1/CDK4, cyclin A, and β-catenin in 
esophageal cancer [26]. Recently, investigators reported 
Fig. 6 Sox6 reversed the proliferation and antiapoptosis effects of H19 knockdown on P19CL6 cells. a CCK-8 assay indicated shH19 boosted the 
viability of P19CL6 cells at day 8 and day 10, and pcDNA-Sox6 reversed the effect. b Cell cycle assay found that shH19 increased the percentage of 
cells in the S phase at day 8 and 10, whereas pcDNA-Sox6 attenuated the effect. (c and d) The rate of apoptosis and caspase-3 activity were signifi-
cantly decreased in cells treated with shH19 at day 8 and 10, and pcDNA-Sox6 overturned the effect. *P < 0.05, **P < 0.01, ***P < 0.001
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that Sox6 played vital roles in cell differentiation and pro-
liferation [27, 28]. In agreement with this, our result indi-
cated that Sox6 down-regulation significantly decreased 
the percentage of apoptotic cells and promoted cell pro-
liferation during late stage of cardiomyocyte differentia-
tion, whereas overexpression of Sox6 played the opposite 
roles. Importantly, Sox6 overexpression reversed the 
effects of H19 knockdown on P19CL6 growth and apop-
tosis during late stage of cardiomyocyte differentiation.
In conclusion, we defined that H19 knockdown pro-
moted P19CL6 cells proliferation and inhibited apoptosis 
by modulating miR-19b. Furthermore, Sox6, as a miR-
19b target, could inhibit P19CL6 cells proliferation and 
promoted apoptosis. Thus, our data indicated that H19 
could inhibit miR-19b expression, and miR-19b targets 
Sox6, regulating cell proliferation and apoptosis during 
late stage of cardiomyocyte differentiation. This study 
provides a theoretical basis for the research on lncRNA 
in the heart development.
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